Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...
The company says preclinical trials demonstrate its signature molecule can help prevent cell damage that can lead to everything from cancer to macular degeneration.
Pegcetacoplan (Syfovre) is now approved in Australia for treating geographic atrophy (GA) secondary to age-related macular ...
HDL cholesterol levels demonstrate a U-shaped association with AMD, in which both high and low levels elevate risk.
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Therapeutic Goods Administration (TGA) has approved SYFOVRE® (pegcetacoplan) for ...
Faricimab should be readministered with caution in patients who develop mild intraocular inflammation with a previous dose of ...